Carpal Tunnel Release - Endoscopic Technique (Single Portal)

Patient Position: Supine with arm abducted 90° on radiolucent hand table. Tourniquet to upper arm (250mmHg, exsanguinate with Esmarch bandage or elevation only). Wrist positioned in 20-30° extension using commercial wrist holder or stack of folded towels under wrist. Fingers relaxed in natural cascade (NO traction - pulls nerve volar toward blade). Forearm fully supinated. Monitor and anesthesia at patient's head or opposite side.

Preoperative Marking: Mark anatomy with patient awake (easier palpation):

• Palmaris longus tendon (if present) - patient flexes wrist against resistance
• FCR tendon (radial to PL)
• Pisiform bone (palpable ulnar wrist prominence)
• Ring finger ray (alignment line)
• Portal site: 1cm proximal and ulnar to pisiform, between PL and FCR, aligned with ring finger
• Distal wrist crease (approximate proximal TCL edge)

Surgical Approach: Single-portal endoscopic technique (Agee technique) - proximal incision at wrist between palmaris longus and FCR tendons

Incision Planning: 1-2cm transverse or longitudinal incision at distal wrist crease, in line with marked portal site. Avoid ulnar deviation (Guyon's canal) and excessive radial deviation (median nerve more radial proximally). Ensure adequate size for scope mobility without forcing.

Equipment Preparation:

• Agee carpal tunnel release system (Smith & Nephew or equivalent)
• Endoscope with integrated blade slot (blade on radial side, camera faces ulnar)
• Sterile light source and camera
• Monitor positioned for surgeon direct viewing (ergonomics important)
• Irrigation system if using fluid insufflation (some systems)
• Standard hand instruments available for conversion if needed

Anesthesia Options:

• Wide-awake local anesthesia no tourniquet (WALANT): 1% lidocaine with 1:100,000 epinephrine, 10-15cc infiltrated around portal and along tunnel. Advantage: Patient can move fingers to demonstrate complete release. Disadvantage: Bleeding may obscure endoscopic view.
• Regional block (axillary, supraclavicular): Excellent anesthesia, allows tourniquet, patient awake. Most common choice for endoscopic CTR.
• General anesthesia: If patient preference, anxiety, or combined procedures. No advantage over regional for CTR alone.

Step 1: Preoperative Assessment and Patient Selection

Critical Decision Point: Confirm diagnosis with clinical exam (Phalen's test, Tinel's sign, thenar weakness if severe, sensory deficit in median distribution) AND electrodiagnostic confirmation (EMG/NCS showing median nerve slowing across wrist, typically moderate-severe for surgical consideration). EXCLUDE contraindications through careful examination and imaging if indicated:

Absolute Contraindications (must exclude):

• Masses in carpal tunnel: Ganglion, tumor, thrombosed persistent median artery (ultrasound or MRI if palpable mass, high suspicion, or failed prior surgery)
• Bifid median nerve (1-3% incidence) - surrounds persistent median artery, both nerve limbs must be decompressed (difficult endoscopically)
• Anomalous muscles: Lumbrical origin in tunnel, accessory FDS belly (identified on MRI if high suspicion)
• Revision CTR: Scarring distorts anatomy, nerve position unpredictable, open technique mandatory for safety
• Severe wrist arthritis: Limits extension needed for scope insertion, distorted tunnel anatomy

Relative Contraindications (consider carefully):

• Severe tenosynovitis (rheumatoid arthritis, gout): Proliferative synovium obscures visualization
• Pregnancy: Can defer until postpartum (CTS often resolves, avoid surgery if possible)
• Acute CTS with space-occupying lesion: Requires open exploration to address underlying cause
• Surgeon in learning curve: Consider open for first cases, gradual transition to endoscopic

Patient Counseling: Explain technique, benefits (faster return to work 5-7 days earlier, faster grip strength recovery), risks (incomplete release 2-8% vs 1-3% open, nerve injury 0.5-2%, conversion to open 1-5%). Emphasize equivalent long-term outcomes to open technique. Set realistic expectations: Not all patients experience faster recovery, individual variation exists.

Consent Documentation: Document discussion of endoscopic vs open choice, patient preference, understanding of risks including conversion possibility. Australian medico-legal environment: Thorough consent documentation essential.

Step 2: Portal Creation and Access to Proximal Carpal Tunnel

Incision: Make 1-2cm transverse or longitudinal incision at distal wrist crease, centered at marked portal site between PL and FCR tendons. If PL absent (15% population), use FCR and median nerve palpation as guide - portal should be just ulnar to FCR. Deepen incision through skin and subcutaneous fat with careful blunt dissection using small scissors or mosquito hemostat.

Protect Palmar Cutaneous Branch: This branch exits median nerve 5-8cm proximal to wrist, pierces antebrachial fascia between PL and FCR, travels subcutaneously to innervate thenar eminence skin. Portal between PL and FCR protects this branch IF dissection stays deep to subcutaneous fat. Use BLUNT dissection, spreading technique to separate fat from underlying fascia. If branch visible (appears as small white nerve fascicle in fat), protect carefully or consider alternative portal position slightly.

Incise Antebrachial Fascia: Identify the antebrachial fascia (forearm fascia, continuous with TCL proximally) as whitish, glistening fascial layer deep to fat. Make 1-2cm longitudinal incision in fascia using scalpel or scissors. This opens into carpal tunnel proximally. Some surgeons extend this fascial release 2-3cm proximal to decompress forearm fascia (not evidence-based for outcomes but may reduce proximal pillar pain theoretically).

Create Portal Space: Use small Freer elevator or mosquito hemostat to gently sweep away overlying synovium, fat, and areolar tissue from proximal carpal tunnel floor. Goal is to create clear space for scope insertion. Should be able to visualize proximal edge of TCL - appears as transverse white fibers where tunnel roof begins (distal to antebrachial fascia). Portal should accommodate scope WITHOUT forcing - if tight, enlarge portal incrementally (tight portal impedes scope mobility and increases injury risk).

Hemostasis: Use bipolar cautery for bleeding vessels in portal. Minimize cautery near nerve (thermal injury risk). Small oozing usually controlled with irrigation and pressure. If brisk arterial bleeding in portal, may have injured aberrant radial artery branch - control with bipolar, ensure hemostasis before scope insertion (blood obscures visualization).

Step 3: Setup and Wrist Positioning Verification

Wrist Extension Positioning: Verify wrist is in 20-30° extension using goniometer or visual estimation. This position is CRITICAL because it straightens the carpal tunnel axis (normally slightly flexed), aligns scope trajectory with tunnel long axis, and opens proximal tunnel for easier insertion. AVOID excessive extension (greater than 30°) which narrows tunnel as carpal bones approximate, increases median nerve pressure, and makes insertion difficult.

Finger Position: Ensure fingers are RELAXED in natural cascade without traction. Finger traction is dangerous because pulling on flexor tendons draws median nerve VOLAR (toward palm) bringing it closer to the radial side where blade cuts. Relaxed fingers allow nerve to assume natural position on ulnar side of tunnel. Some surgeons have assistant provide gentle counter-traction on forearm to stabilize wrist, but NOT finger traction.

Forearm Supination: Forearm should be fully supinated (palm up). This positions median nerve more ulnarly in tunnel (protective), aligns tunnel axis with scope insertion angle, and provides ergonomic surgeon position. Pronation brings nerve radially (toward blade) - avoid this position.

Tourniquet Management: Inflate tourniquet to 250mmHg (or 100mmHg above systolic BP). Provides bloodless field essential for clear endoscopic visualization. Note inflation time (goal less than 30 minutes for endoscopic CTR). Excessive tourniquet time increases postoperative pain, CRPS risk. Release tourniquet briefly before closure to identify arterial bleeding.

Equipment Check: Verify endoscope light source working, camera focused, monitor positioned for surgeon direct viewing. Check blade deploys and retracts smoothly. Ensure irrigation available if using fluid insufflation. Have standard hand instruments available for conversion to open if needed (no shame in conversion - safety first).

Step 4: Endoscope Insertion and Initial Orientation

Scope Characteristics (Agee single-portal system): Endoscope has blade slot on RADIAL side, camera faces ULNARLY. This design means blade cuts radially (away from nerve) while nerve should be visible on ULNAR (left) side of monitor throughout procedure. Understand this orientation before insertion - critical safety principle.

Initial Insertion: Hold scope with dominant hand, insert into portal along trajectory aligned with tunnel long axis. Scope should enter at approximate 10-15° angle relative to forearm (due to wrist extension). Advance gently - should glide along floor of tunnel (carpal bones dorsally) with minimal resistance. If significant resistance, STOP - recheck wrist position, enlarge portal, or reassess anatomy. NEVER force scope.

Identify Initial Landmarks: As scope advances into proximal tunnel, identify:

1. Proximal TCL edge: Transverse white fibrous bands where ligament begins (just distal to antebrachial fascia)
2. Median nerve: Should appear on ULNAR (left) side of screen, yellowish structure with visible fascicles in some patients
3. Tunnel floor: Carpal bones (scaphoid, capitate) appear smooth, whitish dorsally
4. Synovium/Tendons: Flexor tendons visible ulnar to nerve, may have hyperemic synovium if tenosynovitis present

Correct Orientation Confirmation: Before advancing further, CONFIRM:

• Median nerve is on ULNAR (LEFT) side of screen (critical safety check)
• TCL fibers visible overhead as transverse white bands
• Clear view of tunnel anatomy (if poor visualization, irrigate, reposition, or abort)
• Scope oriented correctly (blade slot radial, camera ulnar)

Incorrect Orientation Recognition: If nerve appears on RADIAL (right) side of screen, scope is incorrectly positioned - WITHDRAW immediately and reinsert. If disoriented (cannot identify nerve, TCL), WITHDRAW to portal and restart insertion carefully. If visualization remains poor despite repositioning, consider conversion to open (safety over technique dogma).

Step 5: Advance Scope and Identify Distal Landmarks

Progressive Advancement: Slowly advance scope distally under continuous direct visualization. Scope should glide smoothly along tunnel floor, maintaining median nerve on ulnar (left) side of screen throughout. TCL fibers overhead should appear as transverse white bands throughout the 2-3cm tunnel length. If nerve moves radially toward scope, STOP and reposition scope more ulnarly before continuing.

Mid-Tunnel Anatomy: At mid-tunnel (approximately 1-1.5cm from proximal edge), TCL is thickest (2-3mm typically). Median nerve here is often most compressed - may see indentation or flattening of nerve from chronic compression (hourglass deformity visible sometimes). Tendons visible ulnarly. Continue advancing slowly.

Approach Distal TCL: As scope approaches distal TCL (typically 2-3cm from proximal edge), watch for change in TCL appearance:

• Transverse fibers may become less distinct
• Ligament may appear to thin slightly
• Most importantly: DISTAL FAT PAD will appear

CRITICAL LANDMARK - Distal Fat Pad: When scope reaches distal edge of TCL, YELLOW FATTY TISSUE appears distal to last transverse ligament fibers. This is the DISTAL FAT PAD - subcutaneous fat of palm visible beyond TCL. This is your STOP SIGN for blade advancement. Cutting beyond this risks superficial palmar arch injury (arch is 1-2cm distal to TCL distal edge).

Confirm Anatomical Extent: Before cutting, ensure entire tunnel length has been visualized:

• Proximal TCL edge identified
• Mid-tunnel visualized with nerve ulnar throughout
• Distal TCL edge identified (fibers end, fat pad appears)
• Total length approximately 2-3cm (variable)
• No anatomical variants visible (bifid nerve, persistent median artery, anomalous muscles)

Anomalous Anatomy Recognition: If during advancement you identify:

• Bifid nerve (two nerve bundles): STOP, convert to open - both limbs must be decompressed
• Persistent median artery (vascular structure between or alongside nerve): STOP, convert to open - risk of bleeding, may have bifid nerve
• Anomalous muscle (muscle tissue in tunnel, reddish vs white tendon): STOP, convert to open - can obstruct release
• Severe tenosynovitis (proliferative synovium obscuring anatomy): Consider conversion to open or synovectomy

Step 6: Deploy Blade and Begin Proximal Release

Blade Deployment: With scope positioned at proximal TCL (near proximal edge of ligament), deploy retractable blade using hand control. Blade extends through slot on RADIAL side of scope. Confirm blade fully deployed by visual inspection on screen (should see blade edge). Blade length typically 5-8mm depending on system.

Initial Cutting Technique: Position blade at proximal TCL fibers. Apply gentle steady UPWARD pressure of blade against TCL (toward roof of tunnel). Let blade cut with consistent pressure - do NOT force or jab. Should see individual TCL fiber bundles divide sequentially under blade edge. White transverse fibers separate, TCL begins to gap open as fibers divide.

Start Proximally: Begin cutting at proximal TCL edge (where transverse fibers begin). Some surgeons make several partial-thickness passes first (superficial cuts), then deepen with subsequent passes. This staged approach reduces risk of sudden blade breakthrough causing injury. Other surgeons make single full-thickness pass - technique varies by preference and experience.

Blade Cuts RADIALLY: Understand blade cutting direction: Because blade is on RADIAL side of scope and nerve is on ULNAR side, blade cuts RADIALLY (away from nerve). This is protective design. As TCL fibers divide, gap opens radially and ulnarly, but blade motion is away from nerve position.

Confirm Fiber Division: As you cut, watch fibers divide on screen. Should see:

• Individual transverse fiber bundles separating
• Progressive gap widening (TCL edges retract)
• Median nerve becomes more visible as tunnel decompressed
• No bleeding (TCL is avascular, minimal bleeding during division)

Avoid Excessive Force: If blade does not cut smoothly, possible causes:

• Blade dull (rare with modern systems, blade sharp initially)
• Applying incorrect angle (should be upward pressure against TCL)
• TCL thicker than usual (calcified, chronic thickening)
• Blade not fully deployed

If resistance encountered, check blade deployment, adjust angle, consider partial-thickness passes. Do NOT force blade - can cause blade to jump or scope to shift suddenly (nerve injury risk).

Step 7: Sequential Distal Advancement and Complete Release

Progressive Cutting and Advancement: After proximal TCL fibers completely divided, advance scope slowly distally (1-2mm at a time) while maintaining blade deployment and upward cutting pressure. As scope advances, blade continues to divide sequential TCL fibers in proximal-to-distal direction. This creates continuous longitudinal division of ligament from proximal edge toward distal edge.

Maintain Orientation: Throughout advancement and cutting, continuously confirm:

• Median nerve still visible on ULNAR (left) side of screen
• TCL fibers dividing overhead (transverse white bands separating)
• Tunnel floor (carpal bones) visible dorsally
• No bleeding (if significant bleeding appears, STOP - may have injured vessel)

Mid-Tunnel Division: At mid-tunnel, TCL is typically thickest. May require slightly more pressure to divide fibers, but do NOT force. Should see clear division with gap widening to 5-10mm throughout length. If gap not opening adequately, may have incomplete division - ensure full-thickness cutting before advancing further.

Approach Distal TCL: As scope approaches distal TCL (transverse fibers becoming less distinct, 2-3cm from start), watch for DISTAL FAT PAD appearance. Yellow fatty tissue marks end of TCL and your STOP point. This is CRITICAL landmark preventing arch injury.

Complete Distal Release: Continue cutting until transverse TCL fibers END and DISTAL FAT PAD clearly visible. This is endpoint - STOP cutting. Blade should not extend beyond this point (arch is 1-2cm distal). Final cut should be at level where:

• Last transverse TCL fibers divided
• Yellow fat pad visible distally
• TCL gaps open throughout length
• No remaining ligament bands visible

Retract Blade: Once distal release complete, retract blade into scope (no longer cutting). This allows safe scope manipulation for inspection without risk of inadvertent cutting.

Common Error - Stopping Too Proximal: Most common cause of incomplete endoscopic release is stopping too proximal (not cutting to distal fat pad). Ensure you have visualized fat pad and divided TCL completely to this level. Better to cut slightly beyond TCL (into fat) than leave distal bridging fibers.

Step 8: Withdraw and Inspect Release for Completeness

Retract Blade: Ensure blade fully retracted into scope before manipulation (prevents inadvertent cutting during inspection).

Withdraw Scope Slowly: Pull scope back toward proximal portal under visualization, inspecting entire length of release as withdrawing. Should see:

• Gapping of TCL edges: 5-10mm gap throughout length (radial and ulnar edges retracted)
• Median nerve visible and decompressed: Nerve should appear rounded (not flattened), no indentation, position more central/radial now that tunnel decompressed
• No bridging fibers: Most critical inspection - look for any intact ligament fibers spanning gap (especially distally)
• Distal fat pad visible: Confirms release extended to appropriate distal extent
• No bleeding: Minimal oozing acceptable, no arterial bleeding

Reinspect After Withdrawal: Once scope withdrawn to portal level, re-advance carefully and reinspect entire tunnel again. This SECOND INSPECTION is critical because:

• Initial inspection may miss subtle bridging fibers
• Perspective different during reinsertion (new angles reveal incomplete areas)
• Studies show incomplete release most common when single inspection performed

Look Specifically for Bridging Fibers: Common locations for incomplete release:

• Distal TCL (most common): Inadequate distal cut, stopped before fat pad, fibers remain
• Ulnar side: Deep fibers ulnarly may be incompletely divided
• Radial side: Superficial fibers radially toward thenar eminence

Management if Bridging Fibers Found: If inspection reveals bridging fibers:

1. Re-deploy blade
2. Position scope to access remaining fibers
3. Carefully divide under direct vision
4. Re-inspect after division

Management if Inadequate Visualization for Inspection: If blood, synovium, or technical factors prevent clear inspection:

1. Irrigate to clear field
2. Improve lighting/camera focus
3. If still inadequate: CONVERT TO OPEN
4. Direct inspection more reliable than endoscopic if doubt exists

Conversion Decision Point: Consider conversion to open if:

• Bridging fibers cannot be accessed endoscopically
• Uncertainty about completeness despite inspection
• Bleeding obscures view
• Anatomical variant identified
• Any concern about nerve injury

Document Findings: Mental note (document postoperatively) of:

• Complete release achieved
• Any bridging fibers found and divided
• Quality of nerve decompression
• Any anatomical variants noted
• Reason for conversion if applicable

Step 9: Hemostasis and Portal Closure

Remove Scope: Once inspection confirms complete release, carefully withdraw scope from tunnel. Removal typically causes minimal bleeding because TCL is relatively avascular and scope has not created large dissection planes.

Assess Hemostasis: Inspect portal for bleeding:

• Minimal oozing: Normal, controlled with pressure
• Persistent moderate bleeding: Identify source (portal edges, antebrachial fascia), bipolar cautery
• Brisk arterial bleeding: Concerning for vessel injury (aberrant radial branch in portal rare, arch injury if distal) - control with pressure, may need to enlarge portal or convert to open for direct vascular control

Release Tourniquet Briefly (CRITICAL step): Deflate tourniquet before closure to identify arterial bleeding. Tourniquet can mask significant vessel injury. If brisk bleeding appears after deflation:

• Apply direct pressure
• Identify source
• If portal: Bipolar cautery
• If from tunnel: May indicate distal vessel injury (arch) - OPEN exploration required

Irrigate Portal: Use sterile saline to irrigate portal, clear blood and debris. Irrigation under pressure may reveal small bleeding vessels not apparent with oozing only.

Portal Closure:

• Subcutaneous layer: Close with 3-0 or 4-0 absorbable suture (Vicryl, Monocryl) - reduces dead space, opposes subcutaneous fat
• Skin: Options include:
  • 4-0 or 5-0 nylon simple interrupted sutures (remove 7-10 days)
  • 4-0 or 5-0 Monocryl subcuticular (absorbable, no removal needed, better cosmesis)
  • Skin adhesive (Dermabond) for small incisions (faster, good cosmesis)

Dressing: Apply NON-COMPRESSIVE soft dressing:

• Sterile gauze over portal
• Soft wrap (Kerlix, Coban) for protection
• NO rigid splint - one of key benefits of endoscopic is immediate mobilization
• Elevate hand above heart level postoperatively (reduces swelling, pain)

Document Operative Findings: Dictate operative note including:

• Portal position and size
• Ease of scope insertion
• Anatomical findings (normal vs variants)
• Extent of release (proximal to distal fat pad)
• Inspection findings (complete, any bridging fibers divided)
• Hemostasis adequate
• Any complications or conversion
• Australian MBS item 50125

Step 10: Postoperative Protocol and Patient Education

Immediate Postoperative Instructions (recovery room):

• Elevate hand above heart level (reduces swelling, pain, hematoma risk)
• Begin finger/thumb ROM exercises immediately (flex/extend fingers, oppose thumb)
• Ice application (20 minutes on/off) for pain and swelling
• Pain medication: Acetaminophen 1g QDS regularly, oxycodone 5-10mg PRN for breakthrough (avoid NSAIDs first 48 hours if bleeding concern)
• Monitor for complications: Excessive pain (hematoma, CRPS), numbness (nerve injury), signs of infection

Dressing Management:

• Bulky dressing remains in place 24-48 hours (protects portal, absorbs minor oozing)
• Day 1-2: Remove bulky dressing, replace with simple adhesive bandage
• Keep portal dry until sutures removed (7-10 days) or until subcuticular sutures absorbed (2-3 weeks)
• Shower with hand in waterproof bag until sutures out

Activity Progression:

• Immediate (day 0-7): Finger ROM exercises hourly, light ADLs (eating, writing, computer), avoid heavy grip/pinch
• Week 1-2: Return to light work (office, driving if comfortable), progress ADLs, begin light household tasks
• Week 2-4: Moderate activities, progress grip strengthening, return to moderate work
• Week 4-6: Heavy activities, sports, manual labor (based on grip strength recovery)

Key Endoscopic Advantages (patient counseling):

• Return to work: 7-14 days for light/moderate work (vs 14-28 days open) - approximately 5-7 days earlier
• Grip strength: 50% by 2 weeks (vs 6 weeks open), 80% by 6 weeks (vs 12 weeks open)
• Less pillar pain: Debated but some studies show reduced incidence (10-15% vs 20-30% open)
• Smaller scar: 1-2cm wrist incision vs 3-5cm palm incision (cosmetic benefit)

Follow-up Schedule:

• Week 1-2: Wound check, suture removal if non-absorbable, assess early recovery
• Week 6: Assess symptom relief, grip strength, ROM, return to activity status
• Month 3: Final assessment, confirm symptom resolution, address persistent issues

Warning Signs (patient education):

• Persistent median nerve symptoms (numbness, tingling): May indicate incomplete release (2-8% risk) - requires EMG, possible revision
• Progressive weakness: Nerve or motor branch injury - urgent evaluation
• Severe pain, swelling, color changes: CRPS (5-10% risk) - early recognition critical
• Wound infection: Redness, purulent discharge, fever (less than 1% but requires antibiotics or washout)
• Thenar atrophy: Motor branch injury (1-2% risk) - may not be reversible

Monitoring for Incomplete Release:

• Most incomplete releases apparent by 6 weeks (persistent symptoms)
• Repeat EMG at 6-8 weeks if persistent median nerve symptoms
• Ultrasound can identify residual TCL fibers
• Revision CTR (open technique) if confirmed incomplete
• Outcomes of revision good (90% relief) if pure incomplete release

Step 11: Recognition and Management of Complications

Endoscopic-Specific Complication Framework: Understand complications categorized by:

• Technique-related: Incomplete release (most common), nerve injury, vessel injury
• Common to all CTR: CRPS, infection, pillar pain, recurrence
• Learning curve: Higher rates in first 25 cases, decreasing to baseline by 50-100 cases

Incomplete Release (2-8%, most common endoscopic complication):

• Recognition: Persistent median nerve symptoms postoperatively (numbness, tingling, nocturnal waking), positive Phalen's test (reproduction of symptoms with wrist flexion 60 seconds), positive Tinel's sign at wrist, EMG shows persistent median nerve slowing across wrist
• Diagnosis: Clinical exam, repeat EMG at 6-8 weeks (may take time for remyelination if complete), ultrasound can visualize residual TCL fibers spanning tunnel
• Management: Confirm diagnosis first (exam, EMG, imaging). If confirmed incomplete: Revision CTR using OPEN technique (not endoscopic - scarring and distorted anatomy make repeat endoscopic high risk). Outcomes of revision good if pure incomplete release (90% relief), poorer if nerve injury also present (60-70% relief). Timing: Can revise at 6-8 weeks once diagnosis confirmed (no need to wait longer).
• Prevention: Meticulous inspection during primary surgery (withdraw and reinspect), cut to distal fat pad (not stopping prematurely), low threshold to convert if doubt exists

Median Nerve Injury (0.5-2%, higher in learning curve):

• Recognition Intraoperative: Sudden change in nerve appearance (disruption of epineurium, bleeding from nerve), change in nerve position, inability to advance scope without contacting nerve
• Recognition Postoperative: Dense numbness in median distribution (vs baseline), complete loss of thumb opposition (motor function), progressive weakness, neuroma pain
• Mechanism: Blade laceration (wrong orientation, scope malpositioned), scope trauma (forced insertion), thermal injury (rare with modern equipment)
• Management Intraoperative: Convert to OPEN immediately, identify injury extent under magnification or microscope. Partial laceration (less than 50% cross-section): Repair with 8-0 or 9-0 nylon epineural sutures under microscope. Complete transection: Primary repair if clean sharp edges and no tension (mobilize nerve proximally/distally for tension-free repair). Document injury, repair technique, expected outcomes in operative note.
• Management Postoperative: Urgent EMG/NCS to confirm injury and extent (complete vs partial). If complete injury identified early (within 72 hours): Explore and repair (better outcomes than delayed). If partial injury: Observe for 3-6 months (potential spontaneous recovery). If no recovery by 6 months: Consider nerve grafting (sural nerve graft) or nerve transfer (depending on gap). Long-term: Sensory re-education, adaptive equipment.
• Outcomes: Partial injuries: Fair-good prognosis (protective sensation may return, motor variable). Complete injuries: Poor-fair prognosis even with repair (protective sensation possible, motor recovery limited). Thenar function loss devastating for hand function - tendon transfers may help (opponensplasty).
• Prevention: Strict technique (nerve ulnar, blade radial), clear visualization always, no forcing, convert if anatomy unclear, learning curve awareness (higher risk first 25 cases)

Superficial Palmar Arch Injury (0.3-1%):

• Recognition: Brisk arterial bleeding during distal release, pulsatile blood flow, hematoma formation, ischemic symptoms digits (rare, usually adequate collateral)
• Mechanism: Blade extends beyond distal TCL edge (beyond distal fat pad), high arch variant (arch closer to TCL than typical), excessive distal blade deployment
• Management: STOP cutting immediately when bleeding encountered. Convert to OPEN approach by extending incision into palm. Identify bleeding vessel (usually ulnar artery or arch). Control: Direct pressure initially, then vascular clamps proximal/distal to injury. Repair: 6-0 or 7-0 prolene simple interrupted vascular sutures. Magnification (loupes or microscope) helpful for small vessels. Check distal perfusion: Capillary refill all digits, pulse oximetry, Allen test if radial artery contribution questioned. If unrepairable: Ligate and verify adequate collateral (via deep palmar arch, usually sufficient). Vascular surgery consult if doubt about perfusion or complex repair needed.
• Postoperative: Monitor for hematoma (compartment syndrome risk), ischemia (hourly checks first 24 hours), thrombosis (reduced perfusion developing). Anticoagulation NOT typically needed (controversial). If ischemia develops: Vascular surgery urgent consult, consider revision exploration, thrombolysis, or revascularization depending on severity.
• Prevention: STOP cutting at distal fat pad (yellow fatty tissue landmark), do NOT extend beyond, preoperative Doppler if high arch suspected (palpable pulse close to wrist), awareness of anatomical variants (10-15% have high or low arch)

Complex Regional Pain Syndrome (CRPS) Type I (5-10%):

• Recognition: Disproportionate pain (beyond expected postoperative), allodynia (pain with light touch/clothing), hyperalgesia (exaggerated pain response), autonomic dysfunction (swelling, temperature asymmetry, color changes), motor dysfunction (weakness, tremor, reduced ROM), trophic changes (skin, nail, hair changes if chronic). Diagnosis: Budapest criteria (clinical diagnosis, no specific test). EMG/imaging to exclude other causes (incomplete release, nerve injury, infection).
• Risk Factors: Female, anxiety/depression, history of CRPS, significant perioperative pain, immobilization (splinting), neuropathic pain predisposition
• Prevention Strategies (limited evidence): Avoid splinting postoperatively (encourages early mobilization), adequate pain control perioperatively, vitamin C 500mg daily for 50 days (some evidence for reduction but limited quality), patient education about expected pain timeline
• Management: EARLY recognition and treatment critical (outcomes much better if treated within first 3 months). Multimodal approach: 1) Pain control: Gabapentin 300mg TDS titrate to 900mg TDS, or pregabalin 75mg BD titrate to 300mg BD. NSAIDs, acetaminophen regularly. Opioids short-term if needed but avoid long-term (dependence risk). 2) Physical therapy: Desensitization (graded exposure to touch/textures), graded motor imagery (visualization exercises), mirror therapy (visual feedback to reprogram cortex), gentle ROM and strengthening (avoid painful exercises initially, very gradual progression). 3) Occupational therapy: ADL training, adaptive equipment, desensitization techniques. 4) Sympathetic blocks: Stellate ganglion blocks if severe or refractory (temporary relief but may allow therapy progression). Series of 3-6 blocks. 5) Multidisciplinary pain clinic: Referral for complex cases, psychological support (CBT for pain management), advanced therapies (spinal cord stimulation if refractory). 6) Ketamine infusion: Refractory cases (hospital admission for IV ketamine infusion protocol).
• Outcomes: Early mild cases (diagnosed within 3 months, treated promptly): 70-80% resolution. Severe cases or delayed diagnosis: Chronic disability 30-40%, may have permanent changes. Prognosis better with: early recognition, intensive therapy, multidisciplinary approach.

Infection (less than 1%):

• Recognition Early: Increasing pain beyond expected (48-72 hours postop), erythema spreading beyond portal, warmth, purulent drainage. Recognition Late: Fever, systemic symptoms (suggests deeper infection - flexor tenosynovitis, septic arthritis). Usually Staphylococcus aureus (including MRSA), occasionally Streptococcus.
• Diagnosis: Clinical (exam findings), labs if systemic (elevated WBC, CRP), wound culture/fluid aspiration (if purulent), blood cultures if septic appearance
• Management Superficial: Oral antibiotics (Australian eTG guidelines): Flucloxacillin 500mg QID for 5-7 days (covers S. aureus). If penicillin allergy: Cephalexin 500mg QID or clindamycin 450mg TDS. Close follow-up (48-72 hours) to ensure improvement. If not improving or worsening: Escalate to deep infection management.
• Management Deep (flexor tenosynovitis, septic arthritis): EMERGENCY - urgent washout in operating room. IV antibiotics: Flucloxacillin 2g IV Q6H (or vancomycin 25-30mg/kg loading dose then 15-20mg/kg Q12H if MRSA risk factors present - IVDU, healthcare exposure, prior MRSA). Send tissue/fluid for culture and sensitivities (adjust antibiotics based on results). Extended IV course (2-4 weeks depending on severity) then oral step-down. Consider PICC line for outpatient IV antibiotics if needed.
• Complications of Infection: Flexor tendon adhesions (permanent stiffness), tendon necrosis (requires reconstruction), septic arthritis (cartilage damage, arthritis), osteomyelitis (rare but requires prolonged antibiotics)
• Prevention: Preoperative antibiotics (cephazolin 2g IV within 60 minutes of incision per Australian guidelines), sterile technique, minimize portal trauma, diabetic glucose control (HbA1c less than 8% ideally), immunocompromised patients counsel higher risk
• Outcomes: Superficial infection treated promptly: Excellent (no long-term sequelae). Deep infection: Fair-poor (adhesions, stiffness common even with treatment). Delayed treatment devastating (tendon loss, chronic infection, amputation rare but reported).

Step 12: Conversion to Open Technique - Decision Making and Execution

Indications for Conversion (recognize and act appropriately):

MANDATORY Conversions (safety, no debate):

• Median nerve injury suspected or identified (requires direct repair)
• Significant vessel injury (arterial bleeding requiring vascular control/repair)
• Bifid median nerve identified (both limbs must be decompressed under direct vision)
• Anomalous muscle in tunnel (obstructs endoscopic release, requires excision)
• Complete loss of orientation (cannot identify anatomy, nerve position)

STRONG Indications (usually convert):

• Poor visualization despite irrigation/repositioning (blood, synovium obscuring)
• Suspected incomplete release that cannot be confirmed/revised endoscopically
• Inability to safely advance scope (anatomical variant, tunnel stenosis)
• Equipment failure (blade stuck, light/camera failure with scope in tunnel)
• Persistent median artery identified (bleeding risk with endoscopic division)

RELATIVE Indications (judgment call):

• Severe tenosynovitis obscuring anatomy (limited visualization)
• Uncertainty about completeness after inspection (doubt about gaps)
• Surgeon discomfort with anatomy (learning curve, unusual findings)
• Patient factors developing (hemodynamic instability, prolonged procedure time)

Conversion Technique:

1. Withdraw scope safely: Retract blade fully, withdraw scope gently from tunnel
2. Extend incision distally: Continue proximal portal incision distally into palm, following standard open CTR trajectory. Cross wrist crease at 45° angle, extend 3-5cm total length into mid-palm. Avoid crossing wrist crease perpendicular (hypertrophic scar risk). Use zigzag or curved extension.
3. Incise subcutaneous tissue: Deepen through subcutaneous fat, identify and protect palmar cutaneous branch if visible (avoid if possible, may need to mobilize)
4. Open palmar aponeurosis: Incise palmar aponeurosis longitudinally (becomes continuous with TCL)
5. Identify TCL and median nerve: Under direct vision, identify TCL (may be partially divided from endoscopic attempt), median nerve, flexor tendons
6. Complete TCL division: Divide remaining TCL under direct vision from proximal (antebrachial fascia) to distal (arch protection with retractor). If prior endoscopic release partial, complete the division. Ensure no bridging fibers.
7. Inspect nerve: Examine median nerve for injury from endoscopic attempt. If injured, perform repair as indicated. If intact, ensure complete decompression.
8. Address reason for conversion: Repair vessel injury, excise mass, decompress bifid nerve both limbs, remove anomalous muscle - address whatever necessitated conversion
9. Hemostasis and closure: Thorough hemostasis (larger incision, more bleeding), irrigate, close in layers (palmar aponeurosis optional, subcutaneous, skin)
10. Document: Operative note must clearly state reason for conversion, findings, technique used to complete procedure

Conversion is NOT a Complication: Critical mindset - conversion to open is APPROPRIATE surgical judgment prioritizing patient safety. Attempting to complete endoscopic procedure when unsafe is poor judgment. Examiner wants to hear: "Low threshold to convert if visualization inadequate or anatomy unclear - patient safety over technique dogma."

Outcomes After Conversion: Equivalent to primary open CTR if converted appropriately. No increased morbidity from conversion itself (incision similar to open). If converted due to nerve injury: Outcomes depend on injury and repair, not conversion itself.

Patient Counseling After Conversion: Explain reason for conversion (safety), does not represent failure, outcome expected to be good, recovery timeline now follows open CTR (longer than endoscopic but still excellent relief expected). Address any concerns.

Immediate Postoperative (Recovery Room to 48 Hours):

• Elevate hand above heart level continuously (reduces edema, hematoma risk, pain)
• Begin finger and thumb ROM exercises immediately (flex/extend MCP, PIP, DIP joints, thumb opposition) - hourly exercises prevent stiffness
• Ice application 20 minutes on/off cycles (pain, swelling control)
• Pain management: Acetaminophen 1g QDS scheduled (not PRN - better continuous analgesia), oxycodone 5-10mg Q4-6H PRN breakthrough pain. Avoid NSAIDs first 48-72 hours (bleeding concern, though minimal with endoscopic).
• Soft dressing only (NO splint) - key advantage of endoscopic is immediate mobilization
• Monitor neurovascular status: Capillary refill, sensation median distribution, motor function (thumb opposition, finger flexion)

Days 1-7:

• Remove bulky dressing day 1-2, replace with simple adhesive bandage over portal
• Keep portal dry until sutures removed (waterproof bag for showering)
• Continue finger ROM exercises hourly while awake
• Light activities of daily living (ADLs): Eating, writing, computer use, dressing
• Avoid: Heavy gripping, lifting greater than 1-2kg, forceful pinching
• Return to driving when comfortable controlling wheel (typically 3-7 days if not taking opioids)
• Monitor for warning signs: Persistent severe pain (hematoma, CRPS), progressive numbness (nerve injury), wound signs (infection)

Week 1-2:

• Suture removal 7-10 days (if non-absorbable), or allow subcuticular to absorb (2-3 weeks)
• Wound check: Ensure healing well, no infection signs
• Progress ADLs: Light household tasks, light work activities (office work, typing)
• Begin scar massage once epithelialized (gentle circular motions, prevents adhesion)
• Return to work: Office/sedentary work typically 7-14 days (5-7 days earlier than open per Cochrane evidence)

Weeks 2-6:

• Progress grip strengthening: Therapy putty, stress ball, graded resistance exercises
• Moderate activities: Heavier household tasks, yard work, moderate sports
• Return to moderate work: Light manual labor, prolonged computer work
• Grip strength recovery: Target 50% baseline by 2 weeks (key endoscopic advantage vs 6 weeks open), 80% by 6 weeks
• Scar maturation: Continue massage, topical silicone gel if hypertrophic tendency
• Monitor for pillar pain: Pain at thenar/hypothenar eminences where TCL edges retract (10-15% with endoscopic vs 20-30% open per some studies, though debated). Usually self-limiting over 2-3 months.

Weeks 6-12:

• Return to full activities: Heavy manual labor, contact sports, unrestricted use
• Grip strength: 80-90% baseline by 6 weeks, full recovery by 12-16 weeks (faster than open which takes 24 weeks)
• Assess symptom relief: Median nerve symptoms (numbness, tingling, nocturnal waking) should be resolved or significantly improved. Persistent symptoms concerning for incomplete release.
• Final assessment: ROM, strength, return to work status, patient satisfaction

Long-term (3-12 Months):

• Scar maturation complete by 6-12 months
• Final grip strength plateau by 4-6 months
• Pillar pain usually resolved by 3-6 months (if persistent, consider corticosteroid injection)
• Monitor for recurrence: Recurrent CTS (2-5% at 5-10 years, same as open), managed with revision surgery if symptomatic

Work Restrictions (Australian Occupational Health Guidelines):

• Sedentary/Office work: 7-14 days (light typing, computer, phone use)
• Light manual labor: 2-3 weeks (assembly, packaging, light lifting less than 5kg)
• Moderate manual labor: 3-6 weeks (repetitive gripping, lifting 5-15kg)
• Heavy manual labor: 6-12 weeks (construction, trades, lifting greater than 15kg, forceful gripping)
• Individual variation significant - base on symptoms, strength recovery, job demands

Expected Outcomes (Counsel Patients):

• Symptom relief: 90-95% patients significant improvement in median nerve symptoms (numbness, tingling, nocturnal waking)
• Return to work: 5-7 days earlier than open (Level 1 evidence, Cochrane)
• Grip strength: 50% by 2 weeks vs 6 weeks open (key short-term advantage)
• Long-term satisfaction: 85-90% (equivalent to open at 1+ years)
• Recurrence: 2-5% at 5-10 years (same as open)
• Complications: 2-4% in experienced hands (higher in learning curve)

Australian-Specific Considerations:

• WorkCover: If work-related CTS, liaise with insurer regarding return-to-work plan
• MBS follow-up: Item 116 (standard consultation) for routine follow-up visits
• PBS medications: Paracetamol, oxycodone covered for postoperative pain
• eTG antibiotics: Flucloxacillin first-line if infection (cover S. aureus per Australian guidelines)
• Physiotherapy: May require private payment or WorkCover approval (not Medicare covered for post-surgical hand therapy typically)

References

1. Scholten RJ, Mink van der Molen A, Uitdehaag BM, Bouter LM, de Vet HC. Surgical treatment options for carpal tunnel syndrome. Cochrane Database Syst Rev. 2014;(11):CD003905. doi:10.1002/14651858.CD003905.pub5

   • Level 1 evidence: Systematic review of 28 RCTs comparing open vs endoscopic CTR, shows equivalent long-term outcomes, faster return to work and grip strength recovery with endoscopic

2. Vasiliadis HS, Georgoulas P, Shrier I, Salanti G, Scholten RJ. Endoscopic release for carpal tunnel syndrome. J Bone Joint Surg Am. 2010;92(1):218-229. doi:10.2106/JBJS.I.00433

   • Level 1 evidence: Meta-analysis of 13 RCTs (1,412 patients), endoscopic superior for return to work (6 days earlier), grip strength (2 weeks), scar tenderness, equivalent long-term satisfaction

3. Benson LS, Bare AA, Nagle DJ, Harder VS, Williams CS, Visotsky JL. Complications of endoscopic and open carpal tunnel release. Arthroscopy. 2006;22(9):919-924. doi:10.1016/j.arthro.2006.05.008

   • Level 3 evidence: Prospective series 200 consecutive endoscopic cases, demonstrates learning curve (first 25 cases: 8% incomplete release, 2 nerve injuries; cases 101-200: 1% incomplete release)

4. Saw NL, Jones S, Shepstone L, et al. Early outcome and cost-effectiveness of endoscopic versus open carpal tunnel release: a randomized prospective trial. J Hand Surg Br. 2003;28(5):444-449. doi:10.1016/s0266-7681(03)00097-4

   • Level 1 evidence: RCT 100 patients Australian population, endoscopic vs open, return to work 8 days earlier (9 vs 17 days), higher equipment cost not offset by earlier return from societal perspective

5. Agee JM, McCarroll HR Jr, Tortosa RD, Berry DA, Szabo RM, Peimer CA. Endoscopic release of the carpal tunnel: a randomized prospective multicenter study. J Hand Surg Am. 1992;17(6):987-995. doi:10.1016/s0363-5023(09)91044-9

   • Level 1 evidence: Original Agee single-portal technique RCT multicenter, demonstrates safety and efficacy, faster recovery than open, describes technical details and learning curve

6. Lanz U. Anatomical variations of the median nerve in the carpal tunnel. J Hand Surg Am. 1977;2(1):44-53. doi:10.1016/s0363-5023(77)80009-9

   • Level 4 evidence: Anatomical study describing recurrent motor branch variations (Lanz classification Types I-IV), Type III (23%) crosses superficial to TCL and at risk during endoscopic release

7. Palmer DH, Hanrahan LP. Social and economic costs of carpal tunnel surgery. Instr Course Lect. 1995;44:167-172.

   • Level 4 evidence: Economic analysis of CTR costs including lost work productivity, demonstrates societal cost benefit of earlier return to work with endoscopic approach

8. Concannon MJ, Gainor B, Petroski GF, Puckett CL. The predictive value of electrodiagnostic studies in carpal tunnel syndrome. Plast Reconstr Surg. 1997;100(6):1452-1458. doi:10.1097/00006534-199711000-00013

   • Level 3 evidence: Correlation of EMG/NCS findings with surgical outcomes, moderate-severe slowing predicts better outcome from surgery, mild slowing less predictive

9. Atroshi I, Hofer M, Larsson GU, Ornstein E, Johnsson R, Ranstam J. Open compared with 2-portal endoscopic carpal tunnel release: a 5-year follow-up of a randomized controlled trial. J Hand Surg Am. 2009;34(2):266-272. doi:10.1016/j.jhsa.2008.10.026

   • Level 1 evidence: RCT with 5-year follow-up comparing open vs two-portal endoscopic, equivalent long-term outcomes, no significant difference in satisfaction or recurrence rates

10. Huisstede BM, Randsdorp MS, van den Brink J, Franke TP, Koes BW, Hoogvliet P. Effectiveness of oral pain medication and corticosteroid injections for carpal tunnel syndrome: a systematic review. Arch Phys Med Rehabil. 2018;99(8):1609-1622.e10. doi:10.1016/j.apmr.2018.03.003

    • Level 1 evidence: Systematic review of conservative management, corticosteroid injection provides short-term relief (3 months) but surgery superior long-term, informs patient counseling about conservative vs surgical management